Paresis - 146 Studies Found
Completed |
: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) :
|
Terminated |
: The HAM Infliximab Study : HTLV-I-associated Myelopathy : 2009-01-14 : Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Terminated |
: Safety and Efficiency Study of Valproic Acid In HAM/TSP : HTLV-I-Associated Myelopathy : 2007-08-20 : Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Completed |
: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis : HTLV-I : 2006-06-19 |
Recruiting |
: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis : HTLV-1 : 2006-07-12 : Drug: Hu MiK-Beta-1 |
Enrolling by invitation |
: Urological Physical Therapy in HTLV-1 With Urinary Symptoms :
: 2012-07-25 : Procedure: Urological physical therapy Individual patient attending with one hour duration beginning wit |
Recruiting |
: Evaluation of Patients With HAM/TSP :
: 1999-11-03 |
Completed |
: Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) : Paraparesis Spastic Tropical : 2008-05-19 :
|
Recruiting |
: Raltegravir for HAM/TSP : HTLV-I Infection : 2013-05-21 : Drug: Raltegravir |
Completed |
: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases :
|